Solitary minute hepatocellular carcinoma. A study of 14 patients
Fourteen patients with clinical Stage I hepatocellular carcinoma (T1NOMO) were studied. All patients were asymptomatic, and their conditions were detected by alpha‐fetoprotein (AFP) serosurvey and/or ultrasonography (US) either in the natural population in the early years of the study or in the high...
Gespeichert in:
| Veröffentlicht in: | Cancer 1991-06, Vol.67 (11), p.2855-2858 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2858 |
|---|---|
| container_issue | 11 |
| container_start_page | 2855 |
| container_title | Cancer |
| container_volume | 67 |
| creator | Zhou, Xin‐Da Tang, Zhao‐You Yu, Ye‐Qin Ma, Zeng‐Chen Yang, Bing‐Hui Lu, Ji‐Zhen Lin, Zhi‐Ying Wang, Jie |
| description | Fourteen patients with clinical Stage I hepatocellular carcinoma (T1NOMO) were studied. All patients were asymptomatic, and their conditions were detected by alpha‐fetoprotein (AFP) serosurvey and/or ultrasonography (US) either in the natural population in the early years of the study or in the high‐risk population in the later years of the study. Cirrhosis was present in all patients. Radical resection was performed in all patients. There were no operative deaths or hospital deaths in this series. The 5‐year survival rate after resection was 100%. There were seven long‐term survivors in this series (14.2 years (alive), 11.3 years (alive), 8.8 years (alive), 8.8 years, 7.9 years, 7.6 years (alive), and 7.2 years after resection). The authors discuss aspects concerning early diagnosis, treatment, and prognosis of hepatocellular carcinoma (HCC). |
| doi_str_mv | 10.1002/1097-0142(19910601)67:11<2855::AID-CNCR2820671125>3.0.CO;2-A |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80546484</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80546484</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4725-ad4f5c18e590b85bac074e1a15ad88f4a5c6db6eeaa1fee024692858ed4f7dff3</originalsourceid><addsrcrecordid>eNqVkF9r1EAUxYei1LX2Iwh5En3Ieu9kZjLZihhS_xSKC7aCD8JlNrmxKclmzSTIfnsnbFXsg-DTMJxzz7n3J8Q5whIB5EuELI0BlXyOWYZgAF-YdIX4SlqtV6v84jwuPhafpJVgUkSpXydLWBbrMxnnR2Lxe_yBWACAjbVKvjwSj72_Dd9U6uRYHGMKGRhciDdXfduMbthHXbOdRo5ueOfGvuS2nVo3RKUbymbbd24Z5ZEfp2of9XWEKgquhrejfyIe1q71fHr3nojP795eFx_iy_X7iyK_jEsVOmNXqVqXaFlnsLF640pIFaND7Spra-V0aaqNYXYOa2aQymThXsthLq3qOjkRzw65u6H_PrEfqWv8vKbbcj95sqCVUVYF49eDsRx67weuaTc0XbiQEGgGTDMhmgnRL8BkUkKkGTBRAEx_A6aEgIo1ScpD_NO7PaZNx9Wf8APRoH876D-alvf_2f3P6ntK8hPwl5jE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80546484</pqid></control><display><type>article</type><title>Solitary minute hepatocellular carcinoma. A study of 14 patients</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Zhou, Xin‐Da ; Tang, Zhao‐You ; Yu, Ye‐Qin ; Ma, Zeng‐Chen ; Yang, Bing‐Hui ; Lu, Ji‐Zhen ; Lin, Zhi‐Ying ; Wang, Jie</creator><creatorcontrib>Zhou, Xin‐Da ; Tang, Zhao‐You ; Yu, Ye‐Qin ; Ma, Zeng‐Chen ; Yang, Bing‐Hui ; Lu, Ji‐Zhen ; Lin, Zhi‐Ying ; Wang, Jie</creatorcontrib><description>Fourteen patients with clinical Stage I hepatocellular carcinoma (T1NOMO) were studied. All patients were asymptomatic, and their conditions were detected by alpha‐fetoprotein (AFP) serosurvey and/or ultrasonography (US) either in the natural population in the early years of the study or in the high‐risk population in the later years of the study. Cirrhosis was present in all patients. Radical resection was performed in all patients. There were no operative deaths or hospital deaths in this series. The 5‐year survival rate after resection was 100%. There were seven long‐term survivors in this series (14.2 years (alive), 11.3 years (alive), 8.8 years (alive), 8.8 years, 7.9 years, 7.6 years (alive), and 7.2 years after resection). The authors discuss aspects concerning early diagnosis, treatment, and prognosis of hepatocellular carcinoma (HCC).</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(19910601)67:11<2855::AID-CNCR2820671125>3.0.CO;2-A</identifier><identifier>PMID: 1709061</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; alpha-Fetoproteins - analysis ; Biomarkers, Tumor - blood ; Carcinoma, Hepatocellular - blood ; Carcinoma, Hepatocellular - mortality ; Carcinoma, Hepatocellular - pathology ; Female ; Humans ; Liver Neoplasms - blood ; Liver Neoplasms - mortality ; Liver Neoplasms - pathology ; Male ; Middle Aged ; Neoplasm Staging ; Survival Rate</subject><ispartof>Cancer, 1991-06, Vol.67 (11), p.2855-2858</ispartof><rights>Copyright © 1991 American Cancer Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4725-ad4f5c18e590b85bac074e1a15ad88f4a5c6db6eeaa1fee024692858ed4f7dff3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1709061$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhou, Xin‐Da</creatorcontrib><creatorcontrib>Tang, Zhao‐You</creatorcontrib><creatorcontrib>Yu, Ye‐Qin</creatorcontrib><creatorcontrib>Ma, Zeng‐Chen</creatorcontrib><creatorcontrib>Yang, Bing‐Hui</creatorcontrib><creatorcontrib>Lu, Ji‐Zhen</creatorcontrib><creatorcontrib>Lin, Zhi‐Ying</creatorcontrib><creatorcontrib>Wang, Jie</creatorcontrib><title>Solitary minute hepatocellular carcinoma. A study of 14 patients</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Fourteen patients with clinical Stage I hepatocellular carcinoma (T1NOMO) were studied. All patients were asymptomatic, and their conditions were detected by alpha‐fetoprotein (AFP) serosurvey and/or ultrasonography (US) either in the natural population in the early years of the study or in the high‐risk population in the later years of the study. Cirrhosis was present in all patients. Radical resection was performed in all patients. There were no operative deaths or hospital deaths in this series. The 5‐year survival rate after resection was 100%. There were seven long‐term survivors in this series (14.2 years (alive), 11.3 years (alive), 8.8 years (alive), 8.8 years, 7.9 years, 7.6 years (alive), and 7.2 years after resection). The authors discuss aspects concerning early diagnosis, treatment, and prognosis of hepatocellular carcinoma (HCC).</description><subject>Adult</subject><subject>alpha-Fetoproteins - analysis</subject><subject>Biomarkers, Tumor - blood</subject><subject>Carcinoma, Hepatocellular - blood</subject><subject>Carcinoma, Hepatocellular - mortality</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Liver Neoplasms - blood</subject><subject>Liver Neoplasms - mortality</subject><subject>Liver Neoplasms - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Survival Rate</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkF9r1EAUxYei1LX2Iwh5En3Ieu9kZjLZihhS_xSKC7aCD8JlNrmxKclmzSTIfnsnbFXsg-DTMJxzz7n3J8Q5whIB5EuELI0BlXyOWYZgAF-YdIX4SlqtV6v84jwuPhafpJVgUkSpXydLWBbrMxnnR2Lxe_yBWACAjbVKvjwSj72_Dd9U6uRYHGMKGRhciDdXfduMbthHXbOdRo5ueOfGvuS2nVo3RKUbymbbd24Z5ZEfp2of9XWEKgquhrejfyIe1q71fHr3nojP795eFx_iy_X7iyK_jEsVOmNXqVqXaFlnsLF640pIFaND7Spra-V0aaqNYXYOa2aQymThXsthLq3qOjkRzw65u6H_PrEfqWv8vKbbcj95sqCVUVYF49eDsRx67weuaTc0XbiQEGgGTDMhmgnRL8BkUkKkGTBRAEx_A6aEgIo1ScpD_NO7PaZNx9Wf8APRoH876D-alvf_2f3P6ntK8hPwl5jE</recordid><startdate>19910601</startdate><enddate>19910601</enddate><creator>Zhou, Xin‐Da</creator><creator>Tang, Zhao‐You</creator><creator>Yu, Ye‐Qin</creator><creator>Ma, Zeng‐Chen</creator><creator>Yang, Bing‐Hui</creator><creator>Lu, Ji‐Zhen</creator><creator>Lin, Zhi‐Ying</creator><creator>Wang, Jie</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19910601</creationdate><title>Solitary minute hepatocellular carcinoma. A study of 14 patients</title><author>Zhou, Xin‐Da ; Tang, Zhao‐You ; Yu, Ye‐Qin ; Ma, Zeng‐Chen ; Yang, Bing‐Hui ; Lu, Ji‐Zhen ; Lin, Zhi‐Ying ; Wang, Jie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4725-ad4f5c18e590b85bac074e1a15ad88f4a5c6db6eeaa1fee024692858ed4f7dff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Adult</topic><topic>alpha-Fetoproteins - analysis</topic><topic>Biomarkers, Tumor - blood</topic><topic>Carcinoma, Hepatocellular - blood</topic><topic>Carcinoma, Hepatocellular - mortality</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Liver Neoplasms - blood</topic><topic>Liver Neoplasms - mortality</topic><topic>Liver Neoplasms - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhou, Xin‐Da</creatorcontrib><creatorcontrib>Tang, Zhao‐You</creatorcontrib><creatorcontrib>Yu, Ye‐Qin</creatorcontrib><creatorcontrib>Ma, Zeng‐Chen</creatorcontrib><creatorcontrib>Yang, Bing‐Hui</creatorcontrib><creatorcontrib>Lu, Ji‐Zhen</creatorcontrib><creatorcontrib>Lin, Zhi‐Ying</creatorcontrib><creatorcontrib>Wang, Jie</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, Xin‐Da</au><au>Tang, Zhao‐You</au><au>Yu, Ye‐Qin</au><au>Ma, Zeng‐Chen</au><au>Yang, Bing‐Hui</au><au>Lu, Ji‐Zhen</au><au>Lin, Zhi‐Ying</au><au>Wang, Jie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Solitary minute hepatocellular carcinoma. A study of 14 patients</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1991-06-01</date><risdate>1991</risdate><volume>67</volume><issue>11</issue><spage>2855</spage><epage>2858</epage><pages>2855-2858</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>Fourteen patients with clinical Stage I hepatocellular carcinoma (T1NOMO) were studied. All patients were asymptomatic, and their conditions were detected by alpha‐fetoprotein (AFP) serosurvey and/or ultrasonography (US) either in the natural population in the early years of the study or in the high‐risk population in the later years of the study. Cirrhosis was present in all patients. Radical resection was performed in all patients. There were no operative deaths or hospital deaths in this series. The 5‐year survival rate after resection was 100%. There were seven long‐term survivors in this series (14.2 years (alive), 11.3 years (alive), 8.8 years (alive), 8.8 years, 7.9 years, 7.6 years (alive), and 7.2 years after resection). The authors discuss aspects concerning early diagnosis, treatment, and prognosis of hepatocellular carcinoma (HCC).</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>1709061</pmid><doi>10.1002/1097-0142(19910601)67:11<2855::AID-CNCR2820671125>3.0.CO;2-A</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-543X |
| ispartof | Cancer, 1991-06, Vol.67 (11), p.2855-2858 |
| issn | 0008-543X 1097-0142 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_80546484 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Adult alpha-Fetoproteins - analysis Biomarkers, Tumor - blood Carcinoma, Hepatocellular - blood Carcinoma, Hepatocellular - mortality Carcinoma, Hepatocellular - pathology Female Humans Liver Neoplasms - blood Liver Neoplasms - mortality Liver Neoplasms - pathology Male Middle Aged Neoplasm Staging Survival Rate |
| title | Solitary minute hepatocellular carcinoma. A study of 14 patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T20%3A58%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Solitary%20minute%20hepatocellular%20carcinoma.%20A%20study%20of%2014%20patients&rft.jtitle=Cancer&rft.au=Zhou,%20Xin%E2%80%90Da&rft.date=1991-06-01&rft.volume=67&rft.issue=11&rft.spage=2855&rft.epage=2858&rft.pages=2855-2858&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/1097-0142(19910601)67:11%3C2855::AID-CNCR2820671125%3E3.0.CO;2-A&rft_dat=%3Cproquest_cross%3E80546484%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80546484&rft_id=info:pmid/1709061&rfr_iscdi=true |